90929-70-7 Usage
Uses
Used in Pharmaceutical Industry:
2,3-dimethoxybenzo[f]pyrido[1,2-b]isoquinolinium is used as a drug candidate for its potential anti-cancer properties, making it valuable in the development of novel therapeutic agents for cancer treatment. Its unique molecular structure may contribute to its effectiveness in targeting and combating cancer cells.
2,3-dimethoxybenzo[f]pyrido[1,2-b]isoquinolinium is also used as a drug candidate for its potential anti-inflammatory properties, which could be beneficial in the treatment of various inflammatory conditions. Its specific chemical features may allow for targeted intervention in inflammatory processes, offering new avenues for managing such diseases.
In Medicinal Chemistry Research:
2,3-dimethoxybenzo[f]pyrido[1,2-b]isoquinolinium serves as a subject of study for researchers interested in exploring the mechanisms of drug action. Its unique structure and potential biological activities provide insights into how compounds can interact with biological systems, potentially leading to the discovery of new therapeutic approaches and drug design strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 90929-70-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,9,2 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 90929-70:
(7*9)+(6*0)+(5*9)+(4*2)+(3*9)+(2*7)+(1*0)=157
157 % 10 = 7
So 90929-70-7 is a valid CAS Registry Number.
90929-70-7Relevant academic research and scientific papers
Synthesis of Naphthoquinolizidines - Analogs of Cryptopleurine
Mukerjee, Y. N.,Gaur, S. P.,Jain, P. C.,Anand, Nitya
, p. 985 - 987 (2007/10/02)
Condensation of the appropriate bromomethylnaphthalene (I) with 2-(1,3-dioxa-2-cyclopentyl)pyridine followed by treatment with 48percent HBr affords 3-methoxynaphthoquinolizinium bromide (8), 3-methoxy-(9)-, 2-methoxy-(10)- and 2,3-dimethoxy-(11)-naphthoquinolizinium bromides.The compounds (8-11) on catalytic hydrogenation over PtO2 give the corresponding naphthoquinolizidines (12-15).None of these compounds show any significant anticancer activity.
